Citadel Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $38K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $42.6K | Sell |
|
|||||
|
2023
Q4 | $155K | Buy |
|
|||||
|
2023
Q3 | $48.6K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.92K | Sell |
|
|||||
|
2022
Q4 | $44.7K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $20K | Buy |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $153K | Sell |
|
|||||
|
2021
Q3 | $369K | Buy |
|
|||||
|
2021
Q2 | $316K | Buy |
|
|||||
|
2021
Q1 | $233K | Sell |
|
|||||
|
2020
Q4 | $409K | Sell |
|
|||||
|
2020
Q3 | $9.07M | Buy |
|
|||||
|
2020
Q2 | $1.12M | Sell |
|
|||||
|
2020
Q1 | $2.53M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $30K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $66K | Buy |
|
|||||
|
2018
Q4 | $35K | Sell |
|
|||||
|
2018
Q3 | $125K | Buy |
|